Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre studyOlga Nigro, Corrado Ficorella, Paola Bordi et al.|European Journal of Cancer|2020Cited by 71
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyV. Fanotto, Giuseppe Aprile, Mario Uccello et al.|The Oncologist|2017Cited by 35
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyV. Fanotto, Giuseppe Aprile, Mario Uccello et al.|The Oncologist|2018Cited by 8
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre studyOlga Nigro, Corrado Ficorella, Graziella Pinotti et al.|medRxiv|2020Cited by 6